Atovaquone

Composition

This formulation contains Atovaquone as active ingrediant.

Indications

Used to treat and prevent Pneumocystis jiroveci pneumonia (PCP), a serious lung infection caused by a fungus.

Side effects

Side effects may include nausea, vomiting, diarrhea, stomach pain, headache, and rash.

Precautions

Cautiously used in patients with liver disease, kidney disease

Contraindications

Contraindicated in patients with a known hypersensitivity to atovaquone

Dosage and administration

As directed by Physician

Countries

Worldwide

Available Forms

Tablets, suspension

Manufacturing Services

Third Party Manufacturing Company WHO, GMP, EUGMP, USFDA, In India | Contract Manufacturing Organization (CMO) WHO, GMP, EUGMP, USFDA Services in India, Mumbai, Navi Mumbai| Contract Development and Manufacturing Organization (CDMO) WHO, GMP, EUGMP, USFDA - Services in India | Pharmaceutical Contract Manufacturing Company WHO, GMP, EUGMP, USFDA in Navi Mumbai, India | Top Pharmaceutical Product Exporters, Suppliers, Distributer WHO, GMP, EUGMP, USFDA in Mumbai